Pharmacogenomic Information In The Treatment Of Major Depression: Results From A Randomized Clinical Trial

Miquel Tuson; Víctor Pérez; Ariana Salavert; Jordi Espadaler; Jerónimo Saíz; Julio Bobes; Eduard Vieta; Enric Álvarez; José M. Menchón

doi:10.1016/j.euroneuro.2016.09.388

Related publications

Article2016

Effectiveness of pharmacogenetic information in the treatment of major depressive disorder: results from the AB-GEN randomized clinical trial

Víctor Pérez, Jordi Espadaler, Miquel Tuson, Ariana Salavert, Jerónimo Saíz, Julio Bobes, Eduard Vieta, Enric Álvarez, José M. Menchón

Article2017

Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: results of a randomized, double-blind clinical trial

Víctor Pérez, Ariana Salavert, Jordi Espadaler, Miquel Tuson, Jerónimo Sáiz-Ruiz, Cristina Sáez-Navarro, Julio Bobes, Enrique Baca‐García, Eduard Vieta, J.M. Olivares, Roberto Rodriguez-Jimenez, José María Villagrán Moreno, Josep Gascón, José Cañete, Montse Solé, Pilar A. Sáiz, Ángela Ibáñez, Javier de Diego-Adeliño, José M. Menchón

Article2021

The impact of providing personalized depression risk information on self‐help and help‐seeking behaviors: Results from a mixed methods randomized controlled trial

JianLi Wang, Heidi Eccles, Norbert Schmitz, Scott Burton Patten, Bonnie Lashewicz, Douglas G. Manuel

Article2020

Does providing personalized depression risk information lead to increased psychological distress and functional impairment? Results from a mixed-methods randomized controlled trial

JianLi Wang, Heidi Eccles, Molly Nannarone, Norbert Schmitz, Scott Burton Patten, Bonnie Lashewicz

Article2015

Cognitive-behavioral treatment of insomnia and depression in adolescents: A pilot randomized trial

Gregory N. Clarke, Eleanor L. McGlinchey, Kerrie Hein, Christina M. Gullion, John F. Dickerson, Michael C. Leo, Allison G Harvey